Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?. Journal of Renal and Hepatic Disorders, [S. l.], v. 4, n. 1, p. 18–21, 2020. DOI: 10.15586/jrenhep.2020.68. Disponível em: https://www.jrenhep.com/index.php/jrenhep/article/view/68. Acesso em: 5 jul. 2025.